NewsRack: 'everywhere' news in 'IP' topic for user vishwas

Supreme Court rules for Monsanto in Indiana farmer's GM seeds case	13.5.2013	The Guardian -- World Latest
Justice Elena Kagan says Vernon Bowman's late-season soybean crop infringed on patent for GM soybeans The US Supreme Court came down solidly on the side of the agricultural giant Monsanto on Monday, ruling unanimously that an Indiana farmer could not use patented genetically modified soybeans to create new seeds without paying the company. The case – which was cast by the farmer's supporters as a classic tale of David vs Goliath – could well dictate the future of modern farming. In an unanimous ruling written by Justice Elena Kagan, the court ruled that the farmer, Vernon Bowman, had infringed on Monsanto's patent for its GM soybeans when he bought some of those seeds from a local grain elevator and planted them for a second, late-season crop . Monsanto sued, arguing that Bowman had signed a contract when he initially bought the Roundup Ready soybeans in the spring, agreeing not to save any of the harvest for replanting. The seeds are genetically modified to be resistant to Roundup Ready ...
Also found in: [+]
Dealing with a cussed Pakistan (Cached)	4.5.2013	TOI: Editorial
Dealing with a cussed Pakistan
Also found in: [+]
EU debates biopiracy law to protect indigenous people	1.5.2013	Guardian: Environment
Pharmaceutical firms would need to compensate indigenous people for using their knowhow in creating new medicines The European parliament is debating a draft biopiracy law requiring industry to compensate indigenous people if it makes commercial use of local knowledge such as plant-based medicines. Under the law – based on the international convention on access to biodiversity, the Nagoya protocol – the pharmaceuticals industry would need the written consent of local or indigenous people before exploring their region's genetic resources or making use of their traditional knowhow. Relevant authorities would have the power to sanction companies that fail to comply, protecting local interests from the predatory attitude of big European companies. German firm patents South African herb The draft report on access to genetic resources by Green MEP Sandrine Bélier cites as an example a German pharmaceutical company's dealings in South Africa. Pelargonium sidoides, a variety of ...
Also found in: [+]
License for Manufacturing Generic Anti-Cancer Drugs (Cached)	30.4.2013	Govt of india: PIB
License for Manufacturing Generic Anti-Cancer Drugs
Also found in: [+]
Drug donations are great, but should Big Pharma be calling the shots?	29.4.2013	The Guardian -- World Latest
Giving out free medicines allows pharmaceutical companies to decide which diseases are treated – and which aren't In the early 2000s, pharmaceutical companies were high on activists' hit lists, prompted by Big Pharma's ill-advised attempt to sue the South African government for patent infringement on HIV drugs; an attempt to deal with the country's epidemic by allowing cheaper, generic copies to be sold. Today, the discourse seems merrier. Charities and NGOs sit down with the same companies, discussing how best to confront public health challenges in the developing world. The talk is of partnerships and "win-wins". It isn't all idle chatter. Drug donations, reinvestment of profits in developing countries and a more flexible approach to intellectual property have all signalled a more collaborative approach, with the likes of GlaxoSmithKline, Sanofi, Johnson and Johnson and Merck all performing well in the 2012 Access to Medicine index . But while talk of a new era of friendship is ...
Also found in: [+]
Steps Taken to Strengthen IPR Capibilities (Cached)	29.4.2013	Govt of india: PIB
Steps Taken to Strengthen IPR Capibilities
Also found in: [+]
Little support for pharma MNCs on patent issue (Cached)	27.4.2013	TOI: Intl Business
Multinational drug companies that are complaining against the Indian government and patent authorities using flexibilities under the World Trade Organisation’s Agreement on Trade Related Aspects of Intellectual Property rights are finding little support in the international community.
Also found in: [+]
Margaret Hodge urges accountancy code of practice over role in tax laws	26.4.2013	The Guardian -- Front Page
Committee says accountancy firms using knowledge gained from staff seconded to Treasury to help clients avoid taxes The so-called big four accountancy firms are using knowledge gained from staff seconded to the Treasury to help wealthy clients avoid paying UK taxes, according to a report by the Commons public accounts committee. Deloitte, Ernst & Young, KPMG and PricewaterhouseCoopers have provided the government with expert accountants to draw up tax laws. But the firms went on to advise multinationals and individuals on how to exploit loopholes in legislation they helped to write, the committee found. Margaret Hodge, the committee's chair, said the actions of the accountancy firms were tantamount to a scam and represented a "ridiculous conflict of interest" that must be stopped. "The large accountancy firms are in a powerful position in the tax world and have an unhealthily cosy relationship with government," she said, calling for the Treasury to stop accepting their staff to draw up ...
Also found in: [+]
Accountancy firms 'use knowledge of Treasury to help rich avoid tax' – MPs	26.4.2013	The Guardian -- Front Page
Experts offering advice on legislation they helped to create is 'ridiculous conflict of interest', says select committee chair The so-called "big four" accountancy firms are using knowledge gained from staff seconded to the Treasury to help wealthy clients avoid paying UK taxes, a report by the influential Commons public accounts committee says. Deloitte, Ernst & Young, KPMG and PricewaterhouseCoopers have provided the government with expert accountants to draw up tax laws. But the firms went on to advise multinationals and individuals on how to exploit loopholes around legislation they had helped to write, the public accounts committee (PAC) found. Margaret Hodge, the PAC's chair, said the actions of the accountancy firms were tantamount to a scam and represented a "ridiculous conflict of interest" which must be stopped. "The large accountancy firms are in a powerful position in the tax world and have an unhealthily cosy relationship with government," she said, calling for the Treasury ...
Also found in: [+]
DNA double helix: the discovery that led to 60 years of biological revolution	25.4.2013	Guardian: Science
Six decades after DNA's shapely curves were first revealed, no aspect of biology is now above modification, remix or redesign The myth is that science proceeds in fits and starts, with eureka moments delivering revelation and revolution. The reality is usually much more mundane: a case of scientists grinding out small, incremental advances. But the publication 60 years ago of Francis Crick and James Watson's celebrated structure of DNA – the twisted ladder of the double helix – can legitimately be regarded as a turning point: our understanding of life was changed forever that day, and the modern era of biology began. "It has not escaped our notice," they wrote in a brief paper in the journal Nature , that the double helix "immediately suggests a copying mechanism for the genetic material." And so it does. This elegant spiral, first drawn by Crick's wife Odile, depicts life's most famous molecule. Nowadays it is part of our culture: in films, as art, on shampoo adverts. We now know that DNA ...
Also found in: [+]
Gene patents are a hindrance to innovation \| Adam Rutherford	24.4.2013	Guardian: Comment is Free
Scientists researching diseases such as cancer are impeded by having to pay companies who own specific gene patents You carry a set of instructions in every cell, encrypted in DNA. Your genome , 3 billion letters of genetic code, is not only unique to you now, but is unique to every human who has ever and will ever exist. It contains about 22,000 genes and it was a surprise to geneticists on completion of the Human Genome Project in April 2003 that we bear so few, fewer than a roundworm. But what you might find even more shocking is that hundreds, possibly thousands of these genes are effectively owned by someone else . The birth of gene patenting rapidly followed our ability to read human genes in the 1990s, and in general patents cover the processes of extracting, reading and diagnostic tests for specific bits of an individual's DNA. There is a myth that one fifth of the genes that each of us bears in our cells are patented, but this does not quite stand up to close scrutiny: the language ...
Also found in: [+]
Government's Stand on Generic Drugs (Cached)	23.4.2013	Govt of india: PIB
Government's Stand on Generic Drugs
Also found in: [+]
Can human genes be patented? US Supreme Court to decide (Cached)	15.4.2013	CNN-IBN Top Stories
The US Patent and Trademark Office has been awarding patents on human genes for almost 30 years.
Also found in: [+]
India refutes US criticism of its FDI, IPR laws (Cached)	13.4.2013	Rediff: Business
USTR has said India imposed several barriers in major services industries such as insurance, banking, audiovisual, accounting, legal, telecommunications, distribution services, postal and express delivery services.
Also found in: [+]
Should pharma MNCs be peeved? (Cached)	12.4.2013	Rediff: Business
In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.
Also found in: [+]
Should pharma MNCs be peeved? (Cached)	12.4.2013	Rediff: Columns
In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.
Also found in: [+]
US supreme court to decide if companies can patent human genes	11.4.2013	The Guardian -- World Latest
Utah biotech firm to argue its patents on breast and ovarian cancer genes are necessary to fund further research The US supreme court will hear oral arguments next week to decide whether companies can patent human genes, in a landmark case which could alter the course of US medical research and the battle against diseases such as breast and ovarian cancer. A coalition of scientists, cancer survivors, patients, breast cancer groups and professional medical associations, which has brought the case, will argue that genes are "products of nature", like organs of the body and should not be exploited for commercial gain. Such patents are illegal and violate the first amendment, they say. They are challenging patents on two genes linked to breast and ovarian cancer owned by Myriad Genetics, a biotechnology company, because they say the patents have stymied research and the free exchange of ideas. Myriad, based in Salt Lake City, Utah, will ask the court to uphold the patents, which it says is ...
Also found in: [+]
Govt assures to protect local textile sector (Cached)	11.4.2013	The Assam Tribune
Govt assures to protect local textile sector
Also found in: [+]
Indian patent rulings may face legal heat internationally (Cached)	11.4.2013	ET: Policy
Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India
Also found in: [+]
Novartis case:Supreme Court ruling wise and balanced (Cached)	10.4.2013	Rediff: Interviews
Supreme Court is saying that consumers should not be forced to pay higher prices just because it is chemically a new drug unless there is a therapeutic benefit involved.
Also found in: [+]

1 to 20 of 2,121